AAAAAA
Results:
1-16
|
Results: 16
Authors:
Marsh, A
Spurdle, AB
Turner, BC
Fereday, S
Thorne, H
Pupo, GM
Mann, GJ
Hopper, JL
Sambrook, JF
Chenevix-Trench, G
Citation: A. Marsh et al., The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia, BREAST CA R, 3(5), 2001, pp. 346-349
Authors:
Turner, BC
Perkins, DD
Fairfield, A
Citation: Bc. Turner et al., Neurospora from natural populations: a global study, FUNGAL G B, 32(2), 2001, pp. 67-92
Authors:
Turner, BC
Citation: Bc. Turner, Geographic distribution of neurospora spore killer strains and strains resistant to killing, FUNGAL G B, 32(2), 2001, pp. 93-104
Authors:
Turner, BC
Krajewski, S
Krajewska, M
Takayama, S
Gumbs, AA
Carter, D
Rebbeck, TR
Haffty, BG
Reed, JC
Citation: Bc. Turner et al., BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer, J CL ONCOL, 19(4), 2001, pp. 992-1000
Authors:
Turner, BC
Reed, JC
Citation: Bc. Turner et Jc. Reed, BAG-1 immunostaining and survival in early breast cancer - In reply, J CL ONCOL, 19(16), 2001, pp. 3706-3707
Authors:
Turner, BC
Jenkins, E
Kerr, D
Sherwin, RS
Cavan, DA
Citation: Bc. Turner et al., The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes, DIABET CARE, 24(11), 2001, pp. 1888-1893
Authors:
Browne, DL
Avery, L
Turner, BC
Kerr, D
Cavan, DA
Citation: Dl. Browne et al., What do patients with diabetes know about their tablets?, DIABET MED, 17(7), 2000, pp. 528-531
Authors:
Smith, TE
Lee, D
Turner, BC
Carter, D
Haffty, BG
Citation: Te. Smith et al., True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, INT J RAD O, 48(5), 2000, pp. 1281-1289
Authors:
Turner, BC
Gumbs, AA
Carter, D
Glazer, PM
Haffty, BG
Citation: Bc. Turner et al., Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation, INT J RAD O, 47(5), 2000, pp. 1169-1176
Authors:
Yoo, SS
Carter, D
Turner, BC
Sasaki, CT
Son, YH
Wilson, LD
Glazer, PM
Haffty, BG
Citation: Ss. Yoo et al., Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation, INT J CANC, 90(1), 2000, pp. 22-28
Authors:
Lehman, TA
Haffty, BG
Carbone, CJ
Bishop, LR
Gumbs, AA
Krishnan, S
Shields, PG
Modali, R
Turner, BC
Citation: Ta. Lehman et al., Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer, CANCER RES, 60(4), 2000, pp. 1062-1069
Authors:
Turner, BC
Gumbs, AA
Carbone, CJ
Carter, D
Glazer, PM
Haffty, BG
Citation: Bc. Turner et al., Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy, CANCER, 88(5), 2000, pp. 1091-1098
Authors:
Krajewski, S
Krajewska, M
Turner, BC
Pratt, C
Howard, B
Zapata, JM
Frenkel, V
Robertson, S
Ionov, Y
Yamamoto, H
Perucho, M
Takayama, S
Reed, JC
Citation: S. Krajewski et al., Prognostic significance of apoptosis regulators in breast cancer, ENDOCR-R CA, 6(1), 1999, pp. 29-40
Authors:
Turner, BC
Glazer, PM
Haffty, BG
Citation: Bc. Turner et al., BRCA1/BRCA2 in breast-conserving therapy, J CL ONCOL, 17(11), 1999, pp. 3689-3689
Authors:
Turner, BC
Harrold, E
Matloff, E
Smith, T
Gumbs, AA
Beinfield, M
Ward, B
Skolnick, M
Glazer, PM
Thomas, A
Haffty, BG
Citation: Bc. Turner et al., BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patientsafter lumpectomy and radiation therapy: Implications for breast-conservingmanagement in patients with BRCA1/BRCA2 mutations, J CL ONCOL, 17(10), 1999, pp. 3017-3024
Authors:
Turner, BC
Zhang, J
Gumbs, AA
Maher, MG
Kaplan, L
Carter, D
Glazer, PM
Hurst, HC
Haffty, BG
Williams, T
Citation: Bc. Turner et al., Expression of AP-2 transcription factors in human breast cancer correlateswith the regulation of multiple growth factor signalling pathways, CANCER RES, 58(23), 1998, pp. 5466-5472
Risultati:
1-16
|